Dr. James Mark Lin, MD

Dr. Lin practices at Stanford Care Digestive Health Center of Pleasanton - HOPD in Pleasanton, California.

Dr. Lin's NPI, 1396864872, was assigned on March 28, 2007. Dr. Lin graduated from Vanderbilt University School Of Medicine in 2005. Dr. Lin holds California license A102814.

Dr. Lin's primary practice is Stanford Care Digestive Health Center of Pleasanton - HOPD, at 5565 W Las Positas Blvd, Pleasanton, CA 94588.

Dr. Lin's primary practice is Stanford Care Digestive Health Center of Pleasanton - HOPD in Pleasanton, California. Dr. Lin is also affiliated with Stanford Health Care Tri-Valley. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Lin to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lin practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Lin's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Lin is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Lin is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroduodenitis and gastroenteritis among the conditions Dr. Lin treats.

CMS data shows 1,178 Medicare services from Dr. Lin across 15 procedure codes in 2024, for 590 Medicare patients. Medicare paid $146,215 for them.

CMS counts 590 Medicare patients who saw Dr. Lin in 2024. The largest group is 65 to 74, with 248 patients. 75% of them have high cholesterol, and 73% have high blood pressure. 22% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Lin's median patient age at 61, with 52% women.

In 2024, Dr. Lin wrote 1,974 Medicare Part D claims for 670 patients. 75% of them were for generic drugs. CMS names the drug for 1,765 of them, across 30 drugs with 11 or more claims each, at $747,008 in total drug cost. In 2023, CMS named 1,520 claims across 26 drugs.

Dr. Lin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lin as offering telehealth. CMS counts 164 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Lin, more than 87% of the clinicians it reports for that procedure.

CMS Open Payments shows 103 general payments to Dr. Lin from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 86% of the total. Creo Medical Inc. paid the most, $1,522.

Dmand AI lists 1 award for Dr. Lin, most recently CMS Stage 1 EHR in 2013.

Dr. Lin graduated from Vanderbilt University School Of Medicine in 2005. Dr. Lin is a member of ACG.

Dr. Lin is in network with 7 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. PPO plans come from the most carriers, 5. Check the plan with the practice before a visit.